β-hydroxy-β-methylbutyrate (HMB) stimulates myogenic cell proliferation, differentiation and survival via the MAPK/ERK and PI3K/Akt pathways

Reut Kornasio, Ingo Riederer, Gillian Butler‐Browne, +3

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Pi3k/akt PathwaysDevelopmental BiologySignaling PathwayCell RegulationCancer Cell Biology +5

Proinflammatory Macrophages Enhance the Regenerative Capacity of Human Myoblasts by Modifying Their Kinetics of Proliferation and Differentiation

Maximilien Bencze, Elisa Négroni, Denis Vallese, +10

Molecular Therapy

ImmunologyImmune RegulationBiological MicroenvironmentsCell ProliferationCellular Physiology +25

In Vivo Myogenic Potential of Human CD133+ Muscle-derived Stem Cells: A Quantitative Study

Elisa Négroni, Ingo Riederer, Soraya Chaouch, +6

Molecular Therapy

Myoblast transfer therapy: is there any light at the end of the tunnel?

Vincent Mouly, Ahmed Aamiri, Sophie Périé, +12

PubMed

Cell TherapyTransgenic Mouse ModelsImmunologyPathologySurgery +15

HGF potentiates extracellular matrix-driven migration of human myoblasts: involvement of matrix metalloproteinases and MAPK/ERK pathway

Mariela González, Wallace de Mello, Gillian Butler‐Browne, +4

Skeletal Muscle

<i>Trypanosoma cruzi</i> infection modulates intrathymic contents of extracellular matrix ligands and receptors and alters thymocyte migration

Vinícius Cotta‐de‐Almeida, Adriana Bonomo, Daniella Arêas Mendes‐da‐Cruz, +6

European Journal of Immunology

Slowing Down Differentiation of Engrafted Human Myoblasts Into Immunodeficient Mice Correlates With Increased Proliferation and Migration

Ingo Riederer, Elisa Négroni, Maximilien Bencze, +7

Molecular Therapy

Human Myoblast Engraftment Is Improved in Laminin-Enriched Microenvironment

Suse Dayse Silva-Barbosa, Gillian Butler‐Browne, Wallace de Mello, +4

Transplantation

Cyclosporine toxicity in rabbits

Aloïs Gratwohl, Ingo Riederer, Emil Graf, +1

Laboratory Animals

Bowel MovementImmunologyGastroenterologyCyclosporine DosePharmacotherapy +14

CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

Fernanda Pinto‐Mariz, Luciana Rodrigues Carvalho, Alexandra Prufer de Queiroz Campos Araújo, +16

Skeletal Muscle